Completion of the Share Capital Increase of the Jordanian Pharmaceutical Manufacturing Co.
Ref. :10666/2025
Date: 18/11/2025
Memo No.
(80/2025)
Members of SDC of Brokers and Custodians
Dear General Manager,
Subject: Completion of the Share Capital Increase of the Jordanian Pharmaceutical Manufacturing Co.
Greetings,
Kindly be informed that the SDC has completed the process of registering the share capital increase of the Jordanian Pharmaceutical Manufacturing Company on Tuesday 18/11/2025. The share capital increase is performed through capitalization and allocating part of the company’s debt to the main debtor shareholder “Dr. Abdel Jabbar Al-Kubaisi”, provided that these shares are under lock-up for one year from the completion date of the issuance procedures at the Jordan Securities Commission (JSC) based upon the Jordan Securities Commission (JSC)’s Board of Commissioners decision no. (381/2025) dated 06/11/2025.
Thereby, the SDC record for the capital of the Jordanian Pharmaceutical Manufacturing Company indicates the following:
| # | Company Name | No. of shares increased | No. of lock-up shares | Registered Share Capital |
ISIN
|
Company No. |
| 1. | Jordanian Pharmaceutical Manufacturing Co. | 11,718,750 | 11,718,750 | 45,416,840 | JO4120411015 | 141204 |
Kind Regards,
Sarah Tarawneh
Chief Executive Officer
